Free Trial

Vicarious Surgical Q4 2022 Earnings Report

Vicarious Surgical logo
$14.09 -1.76 (-11.12%)
As of 01/21/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Vicarious Surgical EPS Results

Actual EPS
-$4.80
Consensus EPS
-$5.40
Beat/Miss
Beat by +$0.60
One Year Ago EPS
-$4.50

Vicarious Surgical Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Vicarious Surgical Announcement Details

Quarter
Q4 2022
Time
After Market Closes

Conference Call Resources

Conference Call Audio

Vicarious Surgical Earnings Headlines

Vicarious Surgical Secures Advisory Role with Former CFO
Did You See Trump’s Manhattan Project Bombshell?
This secret document contains stunning details about Donald Trump’s very first order of business… the minute he steps back into the White House. Because if what’s in this leaked document is even half true (and trust me, it comes from a very, very credible source)... Trump’s first Executive Order would easily be the boldest, most mind-blowing and daring American initiative ANY U.S. President has launched in over 80 years.
BTIG Sticks to Its Hold Rating for Vicarious Surgical (RBOT)
See More Vicarious Surgical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Vicarious Surgical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vicarious Surgical and other key companies, straight to your email.

About Vicarious Surgical

Vicarious Surgical (NYSE:RBOT). operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

View Vicarious Surgical Profile

More Earnings Resources from MarketBeat